CIK 0001799448 · Non-accelerated filer<br>Smaller reporting company
Aligos Therapeutics, Inc.
Sign in to watch- Ticker
- ALGS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (800) 466-6059
- Business address
- ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-20 | Beigelman Leonid President | Conversion | +163,842 | 163,842 | ||
| 2020-10-20 | Beigelman Leonid President | Conversion | +13,559 | 13,559 | ||
| 2020-10-20 | Beigelman Leonid President | Conversion | +13,559 | 13,559 | ||
| 2020-10-20 | Beigelman Leonid President | Conversion | +50,781 | 214,623 | ||
| 2020-10-20 | Beigelman Leonid President | Conversion | +3,359 | 16,918 | ||
| 2020-10-20 | Beigelman Leonid President | Conversion | +3,359 | 16,918 | ||
| 2020-10-20 | Beigelman Leonid President | Conversion | +21,724 | 236,347 | ||
| 2020-10-20 | Beigelman Leonid President | Conversion | +1,437 | 18,355 | ||
| 2020-10-20 | Beigelman Leonid President | Conversion | +1,437 | 18,355 | ||
| 2020-10-20 | Beigelman Leonid President | Conversion · Series A Preferred Stock | −163,842 | 0 | ||
| 2020-10-20 | Beigelman Leonid President | Conversion · Series A Preferred Stock | −13,559 | 0 | ||
| 2020-10-20 | Beigelman Leonid President | Conversion · Series A Preferred Stock | −13,559 | 0 | ||
| 2020-10-20 | Beigelman Leonid President | Conversion · Series B-1 Preferred Stock | −50,781 | 0 | ||
| 2020-10-20 | Beigelman Leonid President | Conversion · Series B-1 Preferred Stock | −3,359 | 0 | ||
| 2020-10-20 | Beigelman Leonid President | Conversion · Series B-1 Preferred Stock | −3,359 | 0 | ||
| 2020-10-20 | Beigelman Leonid President | Conversion · Series B-2 Preferred Stock | −21,724 | 0 | ||
| 2020-10-20 | Beigelman Leonid President | Conversion · Series B-2 Preferred Stock | −1,437 | 0 | ||
| 2020-10-20 | Beigelman Leonid President | Conversion · Series B-2 Preferred Stock | −1,437 | 0 |
Page 12 of 12 · 238 trades